DOI QR코드

DOI QR Code

Papillary Thyroid Carcinoma Treated with Radiofrequency Ablation in a Patient with Hypertrophic Cardiomyopathy: A Case Report

  • Sun, Jianyi (Department of Gastrointestinal and Thyroid Surgery, The First Affiliated Hospital, Medical College, Zhejiang University) ;
  • Liu, Xiaosun (Department of Gastrointestinal and Thyroid Surgery, The First Affiliated Hospital, Medical College, Zhejiang University) ;
  • Zhang, Qing (Department of Gastrointestinal and Thyroid Surgery, The First Affiliated Hospital, Medical College, Zhejiang University) ;
  • Hong, Yanyun (Department of Gastrointestinal and Thyroid Surgery, The First Affiliated Hospital, Medical College, Zhejiang University) ;
  • Song, Bin (Department of Gastrointestinal and Thyroid Surgery, The First Affiliated Hospital, Medical College, Zhejiang University) ;
  • Teng, Xiaodong (Department of Pathology, The First Affiliated Hospital, Medical College, Zhejiang University) ;
  • Yu, Jiren (Department of Gastrointestinal and Thyroid Surgery, The First Affiliated Hospital, Medical College, Zhejiang University)
  • 투고 : 2015.02.01
  • 심사 : 2016.03.11
  • 발행 : 2016.07.01

초록

Standard therapy has not been established for thyroid cancer when a thyroidectomy is contraindicated due to systemic disease. Herein, we reported a patient who had hypertrophic cardiomyopathy and papillary thyroid carcinoma treated by radiofrequency ablation because of inability to tolerate a thyroidectomy. Radiofrequency ablation can be used to treat thyroid cancer when surgery is not feasible, although the long-term outcome needs further observation.

키워드

과제정보

연구 과제 주관 기관 : National Natural Science Foundation of China, The Traditional Chinese Medicine Foundation of Zhejiang Province

참고문헌

  1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-1320
  2. Vives M, Roscoe A. Hypertrophic cardiomyopathy: implications for anesthesia. Minerva Anestesiol 2014;80:1310-1319
  3. Rhim H, Lim HK. Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver 2010;4 Suppl 1:S113-S118 https://doi.org/10.5009/gnl.2010.4.S1.S113
  4. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]. Cancer 1998;83:2638-2648 https://doi.org/10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1
  5. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803 https://doi.org/10.1530/eje.1.02158
  6. Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY, et al. Thyroid carcinoma. J Natl Compr Canc Netw 2010;8:1228-1274 https://doi.org/10.6004/jnccn.2010.0093
  7. Shin JH, Baek JH, Ha EJ, Lee JH. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol 2012;2012:919650
  8. Bernardi S, Dobrinja C, Fabris B, Bazzocchi G, Sabato N, Ulcigrai V, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol 2014;2014:934595
  9. Lee SJ, Jung SL, Kim BS, Ahn KJ, Choi HS, Lim DJ, et al. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma. Korean J Radiol 2014;15:817-826 https://doi.org/10.3348/kjr.2014.15.6.817
  10. Baek JH, Kim YS, Lee D, Huh JY, Lee JH. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol 2010;194:1137-1142 https://doi.org/10.2214/AJR.09.3372
  11. Ha EJ, Baek JH, Lee JH. Moving-shot versus fixed electrode techniques for radiofrequency ablation: comparison in an ex-vivo bovine liver tissue model. Korean J Radiol 2014;15:836-843 https://doi.org/10.3348/kjr.2014.15.6.836
  12. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract 2010;16 Suppl 1:1-43
  13. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003;237:399-407

피인용 문헌

  1. RE: Papillary Thyroid Carcinoma Treated with Radiofrequency Ablation in a Patient with Hypertrophic Cardiomyopathy: A Case Report vol.17, pp.6, 2016, https://doi.org/10.3348/kjr.2016.17.6.965
  2. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery vol.33, pp.2, 2016, https://doi.org/10.1080/02656736.2016.1230893
  3. RE: Management of Low-Risk Papillary Thyroid Microcarcinoma vol.18, pp.2, 2017, https://doi.org/10.3348/kjr.2017.18.2.408
  4. Thyroid Radiofrequency Ablation: Updates on Innovative Devices and Techniques vol.18, pp.4, 2016, https://doi.org/10.3348/kjr.2017.18.4.615
  5. Radiofrequency ablation of primary thyroid carcinoma: efficacy according to the types of thyroid carcinoma vol.34, pp.5, 2016, https://doi.org/10.1080/02656736.2018.1427288
  6. Radial scars/complex sclerosing lesions of the breast: radiologic and clinicopathologic correlation vol.18, pp.None, 2016, https://doi.org/10.1186/s12880-018-0279-z
  7. Management of Low-Risk Papillary Thyroid Cancer vol.33, pp.2, 2016, https://doi.org/10.3803/enm.2018.33.2.185
  8. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis vol.36, pp.1, 2016, https://doi.org/10.1080/02656736.2019.1700559
  9. Comparison of the Ablation and Hyperechoic Zones in Different Tissues Using Microwave and Radio Frequency Ablation vol.38, pp.10, 2016, https://doi.org/10.1002/jum.14958